• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[头孢曲松在妇产科领域组织分布的基础研究]

[Fundamental study on tissue distribution of ceftriaxone in the field of obstetrics and gynecology].

作者信息

Fukuda O, Miyamura S, Inoue S, Maeyama M

出版信息

Jpn J Antibiot. 1984 Dec;37(12):2416-9.

PMID:6098737
Abstract

Fundamental study on tissue distribution of ceftriaxone (Ro 13-9904, CTRX), a new cephalosporin parenteral antibiotic, was studied and the following results were obtained. CTRX had been administered by intravenous drip infusion with 1 g to 9 cases who received simple total hysterectomy. The level of CTRX in the cubital venous serum and uterine arterial serum was determined as well as the tissue concentration in the oviduct, ovary, endometrium, myometrium, cervix uteri and portio vaginalis. The level in the oviduct and portio vaginalis was generally high, although it was observed only in a few cases. The variation of the level in the myometrium was large. CTRX is expected to be clinically useful considering the fact that its half-life time is 8.5 hours, which is longer than that of existing cephalosporin antibiotics.

摘要

对新型头孢菌素类肠外抗生素头孢曲松(Ro 13 - 9904,CTRX)的组织分布进行了基础研究,并获得了以下结果。对9例行单纯全子宫切除术的患者静脉滴注1g头孢曲松。测定了肘静脉血清和子宫动脉血清中头孢曲松的水平,以及输卵管、卵巢、子宫内膜、子宫肌层、子宫颈和阴道部的组织浓度。输卵管和阴道部的浓度一般较高,不过仅在少数病例中观察到。子宫肌层中浓度的变化较大。考虑到其半衰期为8.5小时,比现有头孢菌素类抗生素的半衰期长,预计头孢曲松在临床上会有用。

相似文献

1
[Fundamental study on tissue distribution of ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域组织分布的基础研究]
Jpn J Antibiot. 1984 Dec;37(12):2416-9.
2
[Experimental and clinical evaluation on ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的实验与临床评估
Jpn J Antibiot. 1984 Dec;37(12):2298-303.
3
[Study on transfer of ceftriaxone into female genital organs].[头孢曲松向女性生殖器官转移的研究]
Jpn J Antibiot. 1984 Dec;37(12):2391-6.
4
[Fundamental and clinical evaluation of ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床评估]
Jpn J Antibiot. 1984 Dec;37(12):2397-405.
5
[Pharmacokinetics of ceftriaxone in the peripheral venous serum, uterine arterial serum and intrapelvic genital organs].[头孢曲松在周围静脉血清、子宫动脉血清及盆腔内生殖器官中的药代动力学]
Jpn J Antibiot. 1984 Dec;37(12):2420-6.
6
[Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床研究]
Jpn J Antibiot. 1984 Dec;37(12):2328-37.
7
[Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的药代动力学及临床研究
Jpn J Antibiot. 1984 Dec;37(12):2304-19.
8
[Fundamental and clinical studies on ceftriaxone in the field of obstetrics and gynecology].[头孢曲松在妇产科领域的基础与临床研究]
Jpn J Antibiot. 1984 Dec;37(12):2355-63.
9
[Fundamental and clinical studies of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床研究
Jpn J Antibiot. 1984 Dec;37(12):2406-15.
10
[Fundamental and clinical evaluation of ceftriaxone in the field of obstetrics and gynecology].头孢曲松在妇产科领域的基础与临床评估
Jpn J Antibiot. 1984 Dec;37(12):2338-42.

引用本文的文献

1
The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.基于群体药代动力学的头孢曲松在日本成年人中的药代动力学及疗效预测
Eur J Drug Metab Pharmacokinet. 2009 Apr-Jun;34(2):107-15. doi: 10.1007/BF03191159.